Haemonetics (HAE) Acquisitions (2010 - 2026)

Haemonetics has reported Acquisitions for 10 years, with the latest figure at $60.2 million in Q1 2026.

• For the quarter ending Q1 2026, Acquisitions changed N/A year-over-year to $60.2 million; the trailing twelve-month figure through Mar 2026 stood at $60.2 million (down 60.12% YoY), and the FY2026 full-year result was $60.2 million, down 60.12% from the prior year.
• Acquisitions for Q1 2026 stood at $60.2 million, up from $1.8 million in the prior quarter.
• The five-year high for Acquisitions was $243.9 million in Q4 2023, with the low at $1.8 million in Q3 2024.
• Average Acquisitions over 4 years is $116.5 million, with a median of $104.7 million recorded in 2024.
• Peak annual rise in Acquisitions reached 14.0% in 2022, while the deepest fall reached 14.0% in 2022.
• Tracing HAE's Acquisitions over 4 years: stood at $2.8 million in 2022, then jumped by 8456.21% to $243.9 million in 2023, then sank by 99.28% to $1.8 million in 2024, then jumped by 3329.06% to $60.2 million in 2026.
• The last three Acquisitions figures came in at $60.2 million (Q1 2026), $1.8 million (Q3 2024), and $149.2 million (Q2 2024), per Business Quant data.

Peer Comparison